Abel Jasovich
Impact in
-
- Antibiotic Use and Resistance
- Molecular Medicine top 2%
- Antibiotic Resistance in Bacteria
Papers in
-
- Antibiotic Use and Resistance 5
-
- Antibiotic Resistance in Bacteria 8
- Co-authors
- Rajiv MallickMaría Eugenia OlivaGary DukartCarlos BergalloKoné KanigaChristopher LucastiObiamiwe UmehIan R. Friedland
- Journals
- Journal of Chemotherapy (4 papers)Diagnostic Microbiology and Infectious Disease (2 papers)Urology (1 paper)Clinical Infectious Diseases (1 paper)International Journal of Clinical Practice (1 paper)
- Partner nations
- ArgentinaUnited StatesColombia
In The Last Decade
Abel Jasovich
22 papers receiving 405 citations
Peers
Comparison fields: 5 of 63
- Applied Microbiology and Biotechnology 89
- Molecular Medicine 202
- Pharmacology 226
- Clinical Biochemistry 71
- Critical Care and Intensive Care Medicine 40
Countries citing papers authored by Abel Jasovich
This map shows the geographic impact of Abel Jasovich's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Abel Jasovich with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Abel Jasovich more than expected).
Fields of papers citing papers by Abel Jasovich
This network shows the impact of papers produced by Abel Jasovich. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Abel Jasovich. The network helps show where Abel Jasovich may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Abel Jasovich, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2010 | 3 | |
| 2 | 2010 | 11 | |
| 3 | 2009 | 1 | |
| 4 | Endocarditis due to vancomycin-resistant Enterococcus raffinosus successfully treated with linezolid: case report and review of literature. | 2009 | 9 |
| 5 | 2008 | 79 | |
| 6 | 2008 | 73 | |
| 7 | 2008 | 93 | |
| 8 | 2007 | 7 | |
| 9 | 2006 | 6 | |
| 10 | 2003 | 4 | |
| 11 | 2002 | 9 | |
| 12 | 2002 | 47 | |
| 13 | 2002 | 2 | |
| 14 | 2001 | 5 | |
| 15 | 2001 | 1 | |
| 16 | 2000 | 8 | |
| 17 | [Microbiology and conservative surgery of serious infections of the diabetic foot]. | 1992 | 4 |
| 18 | Chagas' disease and kidney transplantation--follow-up of nine patients for 11 years. | 1992 | 15 |
| 19 | 1985 | 9 | |
| 20 | 1983 | 5 |
About Abel Jasovich
Abel Jasovich is a scholar working on Applied Microbiology and Biotechnology, Molecular Medicine, Pharmacology, Clinical Biochemistry and Epidemiology, having authored 22 papers that have together received 439 indexed citations. Recurring topics across this work include Antibiotics Pharmacokinetics and Efficacy (13 papers), Pneumonia and Respiratory Infections (10 papers), Antibiotic Resistance in Bacteria (8 papers), Antibiotic Use and Resistance (5 papers), Bacterial Identification and Susceptibility Testing (3 papers), Antimicrobial Resistance in Staphylococcus (3 papers), Tuberculosis Research and Epidemiology (2 papers) and Urinary Tract Infections Management (1 paper). The work is most often cited by research in Applied Microbiology and Biotechnology (89 citations), Molecular Medicine (202 citations), Pharmacology (226 citations), Clinical Biochemistry (71 citations) and Critical Care and Intensive Care Medicine (40 citations). Abel Jasovich has collaborated with scholars based in Argentina, United States and Colombia. Frequent co-authors include Rajiv Mallick, María Eugenia Oliva, Gary Dukart, Carlos Bergallo, Koné Kaniga, Christopher Lucasti, Obiamiwe Umeh, Ian R. Friedland, Joel Jiang and Walter Krause Neto. Their work appears in journals such as Journal of Chemotherapy, Diagnostic Microbiology and Infectious Disease, Urology, Clinical Infectious Diseases and International Journal of Clinical Practice.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.